Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.

Volume 2 (2005), Issue 5 (May)

1. Surgical treatment of brain metastasis.
   Int J Clin Oncol, 10(2): 74-80. [Abstract] [Full-text]
2. Follicle stimulating hormone-secreting pituitary microadenoma with fluctuating levels of ovarian hyperstimulation.
   Obstet Gynecol, 105(5): 1215-8. [Abstract] [Full-text]
3. ADAM23 methylation and expression analysis in brain tumors.
   Neurosci Lett, 380(3): 260-4. [Abstract] [Full-text]
4. Active and passive cigarette smoking and risk of intracranial meningioma.
   Neuroepidemiology, 24(3): 117-22. [Abstract] [Full-text]
5. Desmoplastic infantile ganglioglioma: MRI and histological findings case report.
   Neuroradiology, 46(12): 1039-43. [Abstract] [Full-text]
6. Tumor necrosis factor reduces brain tumor growth by enhancing macrophage recruitment and microcyst formation.
   Cancer Res, 65(9): 3928-36. [Abstract] [Full-text]
7. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
   Cancer Res, 65(9): 3846-52. [Abstract] [Full-text]
8. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
   Cancer Res, 65(9): 3617-23. [Abstract] [Full-text]
9. Inactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas.
   Cancer Res, 65(9): 3562-7. [Abstract] [Full-text]
10. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.
    Clin Cancer Res, 11(9): 3475-84. [Abstract] [Full-text]
11. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.
    Clin Cancer Res, 11(9): 3326-34. [Abstract] [Full-text]
12. Usefulness of diffusion/perfusion-weighted MRI in rat gliomas: correlation with histopathology.
    Acad Radiol, 12(5): 640-51. [Abstract] [Full-text]
13. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
    DNA Cell Biol, 24(5): 317-24. [Abstract] [Full-text]
14. miR-15a and miR-16-1 down-regulation in pituitary adenomas.
    J Cell Physiol, 204(1): 280-5. [Abstract] [Full-text]
15. Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development.
    Photochem Photobiol Sci, 4(5): 438-42. [Abstract] [Full-text]
16. Low-grade glial tumor with features of astroblastoma in a dog.
    Vet Pathol, 42(3): 366-9. [Abstract] [Full-text]
17. Perineural spread of cutaneous malignancy to the brain: a review of the literature and five patients treated with stereotactic radiotherapy.
    Cancer, 103(10): 2143-53. [Abstract] [Full-text]
18. Clinical review: Diagnosis and management of pituitary carcinomas.
    J Clin Endocrinol Metab, 90(5): 3089-99. [Abstract] [Full-text]
19. The dynamics of growth hormone (GH) secretion in adult cancer survivors with severe GH deficiency acquired after brain irradiation in childhood for nonpituitary brain tumors: evidence for preserved pulsatility and diurnal variation with increased secretory disorderliness.
    J Clin Endocrinol Metab, 90(5): 2794-803. [Abstract] [Full-text]
20. Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma.
    J Clin Endocrinol Metab, 90(5): 2681-90. [Abstract] [Full-text]
21. Hemifacial spasm due to a tentorial paramedian meningioma: a case report.
    Neurol Sci, 26(1): 46-9. [Abstract] [Full-text]
22. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Nucl Med Biol, 32(4): 367-75. [Abstract] [Full-text]
23. Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains.
    Genetics, 169(4): 2189-97. [Abstract] [Full-text]
24. A rehabilitative approach to the patient with brain cancer.
    Neurol Sci, 26: S51-2. [Abstract] [Full-text]
25. Cell therapies in neuro-oncology.
    Neurol Sci, 26: S43-5. [Abstract] [Full-text]
26. Local drug delivery in recurrent malignant gliomas.
    Neurol Sci, 26: S37-9. [Abstract] [Full-text]
27. Cerebellar mutism in adults after posterior fossa surgery: a report of 2 cases.
    Surg Neurol, 63(5): 476-9. [Abstract] [Full-text]
28. Quantitative analysis of topoisomerase IIalpha to rapidly evaluate cell proliferation in brain tumors.
    Biochem Biophys Res Commun, 331(4): 971-6. [Abstract] [Full-text]
29. Prognostic significance of apoptosis in medulloblastoma.
    Neurosci Lett, 381(1): 69-73. [Abstract] [Full-text]
30. Intracranial metastases from adenocarcinoma of cervix: a case report.
    Int J Gynecol Cancer, 15(3): 561-3. [Abstract] [Full-text]
31. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.
    Acta Neuropathol (Berl), 109(4): 387-92. [Abstract] [Full-text]
32. Redistribution of the water channel protein aquaporin-4 and the K+ channel protein Kir4.1 differs in low- and high-grade human brain tumors.
    Acta Neuropathol (Berl), 109(4): 418-26. [Abstract] [Full-text]
33. Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas.
    Acta Neuropathol (Berl), 109(4): 381-6. [Abstract] [Full-text]
34. Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood.
    Pediatr Neurosurg, 41(1): 15-21. [Abstract] [Full-text]
35. Intracranial meningiomas of childhood and adolescence.
    Pediatr Neurosurg, 41(1): 1-7. [Abstract] [Full-text]
36. Extra-axial ependymoma of posterior fossa extending to the Meckel's cave.
    Clin Neurol Neurosurg, 107(4): 334-6. [Abstract] [Full-text]
37. Tissue plasminogen activator expression in meningiomas and glioblastomas.
    Clin Neurol Neurosurg, 107(4): 296-300. [Abstract] [Full-text]
38. Postoperative care following pituitary surgery.
    J Intensive Care Med, 20(3): 127-40. [Abstract] [Full-text]
39. Brain tumors in children and adolescents: cognitive and psychological disorders at different ages.
    Psychooncology, 14(5): 386-95. [Abstract] [Full-text]
40. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
    Exp Clin Endocrinol Diabetes, 113(4): 214-8. [Abstract] [Full-text]
41. Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients.
    Int J Radiat Oncol Biol Phys, 62(2): 333-41. [Abstract] [Full-text]
42. Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies.
    Int J Radiat Oncol Biol Phys, 62(2): 328-32. [Abstract] [Full-text]
43. Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group.
    Int J Radiat Oncol Biol Phys, 62(2): 318-27. [Abstract] [Full-text]
44. Fluid-attenuated inversion-recovery MR imaging in assessment of intracranial oligodendrogliomas.
    Comput Med Imaging Graph, 29(4): 279-85. [Abstract] [Full-text]
45. LGI1: a gene involved in epileptogenesis and glioma progression?
    Neurogenetics, 6(2): 59-66. [Abstract] [Full-text]
46. Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma.
    J Lipid Res, 46(6): 1278-84. [Abstract] [Full-text]
47. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.
    Oncogene, 24(21): 3427-35. [Abstract] [Full-text]
48. Robustness of gene expression profiling in glioma specimen samplings and derived cell lines.
    Brain Res Mol Brain Res, 136(1): 99-103. [Abstract] [Full-text]
49. (32)P radioisotope therapy for recurrent pilocytic astrocytoma.
    Brachytherapy, 4(2): 171-3. [Abstract] [Full-text]
50. Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats.
    Clin Cancer Res, 11(10): 3821-7. [Abstract] [Full-text]
51. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.
    Clin Cancer Res, 11(10): 3624-32. [Abstract] [Full-text]
52. Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution.
    J Neurol Neurosurg Psychiatry, 76(6): 845-51. [Abstract] [Full-text]
53. Relative contribution of chloride channels and transporters to regulatory volume decrease in human glioma cells.
    Am J Physiol Cell Physiol, 288(6): C1451-60. [Abstract] [Full-text]
54. Helical tomotherapy for craniospinal radiation.
    Br J Radiol, 78(930): 548-52. [Abstract] [Full-text]
55. Differentiation between solitary brain metastasis and high-grade glioma by diffusion tensor imaging.
    Br J Radiol, 78(930): 533-7. [Abstract] [Full-text]
56. High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.
    Cancer Res, 65(10): 4088-96. [Abstract] [Full-text]
57. Gene expression profiling and genetic markers in glioblastoma survival.
    Cancer Res, 65(10): 4051-8. [Abstract] [Full-text]
58. Real-time quantitative PCR analysis of gene dosages reveals gene amplification in low-grade oligodendrogliomas.
    Am J Clin Pathol, 123(6): 900-6. [Abstract] [Full-text]
59. The value of high-field MRI (3T) in the assessment of sellar lesions.
    Eur J Radiol, 54(3): 327-34. [Abstract] [Full-text]
60. Functional recovery of children and adolescents after cerebellar tumour resection.
    Brain, 128: 1428-41. [Abstract] [Full-text]
61. Use of cellular telephones and brain tumour risk in urban and rural areas.
    Occup Environ Med, 62(6): 390-4. [Abstract] [Full-text]
62. Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas.
    Minim Invasive Neurosurg, 48(2): 91-6. [Abstract] [Full-text]
63. Preoperative fMRI, tractography and continuous task during awake surgery for maintenance of motor function following surgical resection of metastatic tumor spread to the primary motor area.
    Minim Invasive Neurosurg, 48(2): 85-90. [Abstract] [Full-text]
64. Impact of intraoperative MRI on the surgical results for high-grade gliomas.
    Minim Invasive Neurosurg, 48(2): 77-84. [Abstract] [Full-text]
65. The expression of rac1 pseudogene in human tissues and in human brain tumors.
    Eur Surg Res, 37(2): 100-4. [Abstract] [Full-text]
66. Cortical mapping by functional magnetic resonance imaging in patients with brain tumors.
    Eur Radiol, 15(6): 1148-58. [Abstract] [Full-text]
67. Lack of association of cytomegalovirus with human brain tumors.
    Mod Pathol, 18(6): 838-43. [Abstract] [Full-text]
68. Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1.
    Integr Cancer Ther, 4(2): 168-77. [Abstract] [Full-text]
69. Task switching after cerebellar damage.
    Neuropsychology, 19(3): 362-70. [Abstract] [Full-text]
70. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib.
    Cancer, 103(11): 2344-8. [Abstract] [Full-text]
71. Arrested spread of vesicular stomatitis virus infections in vitro depends on interferon-mediated antiviral activity.
    Biotechnol Bioeng, 90(7): 793-804. [Abstract] [Full-text]
72. Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas.
    Cancer, 103(11): 2363-72. [Abstract] [Full-text]
73. Detection of somatic TP53 splice site mutations in diffuse astrocytomas.
    Cancer Lett, 224(2): 321-7. [Abstract] [Full-text]
74. Mechanosensation and endothelin in astrocytes--hypothetical roles in CNS pathophysiology.
    Brain Res Brain Res Rev, 48(3): 488-508. [Abstract] [Full-text]
75. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    J Magn Reson Imaging, 21(6): 694-700. [Abstract] [Full-text]
76. Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema.
    J Magn Reson Imaging, 21(6): 701-8. [Abstract] [Full-text]
77. Dynamic susceptibility contrast perfusion imaging of radiation effects in normal-appearing brain tissue: changes in the first-pass and recirculation phases.
    J Magn Reson Imaging, 21(6): 683-93. [Abstract] [Full-text]
78. Isotropic diffusion weighting in radial fast spin-echo magnetic resonance imaging.
    Magn Reson Med, 53(6): 1347-54. [Abstract] [Full-text]
79. Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation.
    Magn Reson Med, 53(6): 1307-16. [Abstract] [Full-text]
80. Gamma knife radiosurgery for tumors involving the cavernous sinus.
    Stereotact Funct Neurosurg, 83(1): 45-51. [Abstract] [Full-text]
81. Apparent diffusion coefficient of human brain tumors at MR imaging.
    Radiology, 235(3): 985-91. [Abstract] [Full-text]
82. The characterization of tumor apoptosis after experimental radiosurgery.
    Stereotact Funct Neurosurg, 83(1): 17-24. [Abstract] [Full-text]
83. Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide.
    Int J Cancer, 116(2): 187-92. [Abstract] [Full-text]
84. Necrotizing vasculopathy of the CNS: case report.
    J Neurooncol, 72(2): 191-3. [Abstract] [Full-text]
85. Neoplastic meningitis-related encephalopathy.
    J Neurooncol, 72(2): 185-9. [Abstract] [Full-text]
86. Bone marrow metastases from glioblastoma multiforme--A case report and review of the literature.
    J Neurooncol, 72(2): 157-61. [Abstract] [Full-text]
87. Apoptotic markers for primary brain tumor prognosis.
    J Neurooncol, 72(2): 151-6. [Abstract] [Full-text]
88. Beauty product-related exposures and childhood brain tumors in seven countries: results from the SEARCH International Brain Tumor Study.
    J Neurooncol, 72(2): 133-47. [Abstract] [Full-text]
89. Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma.
    J Neurooncol, 72(2): 125-31. [Abstract] [Full-text]
90. Alterations of cell cycle regulators in gliomatosis cerebri.
    J Neurooncol, 72(2): 115-22. [Abstract] [Full-text]
91. Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma.
    J Neurooncol, 72(2): 107-13. [Abstract] [Full-text]
92. Aberrant TP53 protein accumulation in the neuronal component of ganglioglioma.
    J Neurooncol, 72(2): 103-6. [Abstract] [Full-text]
93. Comparative genetic analysis of metachronous anaplastic oligoastrocytomas with extended recurrence-free interval.
    J Neurooncol, 72(2): 95-102. [Abstract] [Full-text]
94. Stem cells and brain cancer.
    Exp Cell Res, 306(2): 323-9. [Abstract] [Full-text]

© 2004-2008 Brain Tumors Research Today. All Rights Reserved.